News & Press Releases

The Deal covered Mintz's recent announcement that seven attorneys have been elevated to Member. The publication profiled Eric Blythe, Katya Daniel, and Scott Dunberg, highlighting their focus on restructurings, private equity, and M&A, respectively. 

Members Adam Samansky and Peter Cuomo spoke to Managing IP  on the implications that a pending case in the Court of Appeals for the Federal Circuit could have on litigation and prosecution strategies for life sciences companies.

Members Douglas P. Baumstein, Jacob H. Hupart, and Securities & Capital Markets Chair and Life Sciences Co-Chair Jonathan L. Kravetz, and Associates Will G. McKitterick and Ellen Shapiro authored an article for the New York Law Journal analyzing the role corporate boards play in monitoring and overseeing a company's operations, particularly in light of the SEC's imminent ESG disclosure rules.

Managing Member Bob Bodian sat down for an interview with The American Lawyer to talk about Mintz, in particular return to office, associate hiring, the 2022 market, and what 2023 will have in store.

Mintz Member Laurence J. Freedman spoke to Law360 about the awaited brief from the U.S. Department of Health and Human Services on whether Anti-Kickback Statute cases should show whether health care "remuneration" intentionally impacted medical decision making.

Mintz's Retail and Consumer Products Practice Co-Chair, Charles Samuels, spoke to The Bond Buyer about what potential impact of the Financial Disclosure Transparency Act on the municipal market.